featured
Prolonged Survival in Stage 3 Melanoma With Ipilimumab Adjuvant Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Prolonged Survival in Stage III Melanoma With Ipilimumab Adjuvant Therapy
N. Engl. J. Med 2016 Oct 07;[EPub Ahead of Print], AM Eggermont, V Chiarion-Sileni, JJ Grob, R Dummer, JD Wolchok, H Schmidt, O Hamid, C Robert, PA Ascierto, JM Richards, C Lebbé, V Ferraresi, M Smylie, JS Weber, M Maio, L Bastholt, L Mortier, L Thomas, S Tahir, A Hauschild, JC Hassel, FS Hodi, C Taitt, V de Pril, G de Schaetzen, S Suciu, A TestoriFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.